Inventor · disambiguated record
Nicolas Leupin
Also filed as: LEUPIN NICOLAS
3 granted patents·6 pending applications·10 citations·filing 2018–2025
65Inventor score
Top patents by PatentIndex Score
9 records- 0188US12240875B2Use of FCRN antagonists for treatment of generalized myasthenia gravisargenx BV·Filed 2018·Granted Mar 4, 2025·3 cites·21 claims
- 0285US12202900B2Compositions and methods for treating immune thrombocytopeniaargenx BV·Filed 2019·Granted Jan 21, 2025·4 cites·14 claims
- 0385US11712468B2CD70 combination therapyargenx BV·Filed 2019·Granted Aug 1, 2023·3 cites·36 claims
- 0473US2025215090A1Compositions and methods for treating immune thrombocytopeniaargenx BV·Filed 2024·Application pending·0 cites
- 0571US2024033353A1Cd70 combination therapyargenx BV·Filed 2023·Application pending·0 cites
- 0661US2025152707A1Cd70 combination therapyargenx BV·Filed 2025·Application pending·0 cites
- 0760US2025179133A1Use of fcrn antagonists for treatment of generalized myasthenia gravisargenx BV·Filed 2025·Application pending·0 cites
- 0855US2025230252A1Treatment for acute myeloid leukemia with anti-cd70 antibodiesargenx BV·Filed 2025·Application pending·0 cites
- 0954US2019106498A1Treatment for acute myeloid leukemiaDE HAARD HANS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Leupin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →